LENACAPAVIR
Clinical trials for LENACAPAVIR explained in plain language.
Never miss a new study
Get alerted when new LENACAPAVIR trials appear
Sign up with your email to follow new studies for LENACAPAVIR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Long-Acting HIV shots aim to keep virus undetectable
Disease control Not yet recruitingThis study looks at how well a long-acting injectable combination of two drugs, cabotegravir and lenacapavir, controls HIV. About 50 adults with HIV who are already on or starting this treatment will be followed for a year. The main goal is to see if the virus stays suppressed (b…
Matched conditions: LENACAPAVIR
Sponsor: Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba • Aim: Disease control
Last updated May 26, 2026 06:32 UTC
-
Inoculation against lies: study shields young women from HIV drug myths
Knowledge-focused Not yet recruitingThis study tests whether a short 'inoculation' message can help young women in South Africa resist false claims about lenacapavir, a new twice-yearly injection that prevents HIV. About 1,500 women aged 18-29 will be randomly assigned to receive either the inoculation message or n…
Matched conditions: LENACAPAVIR
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC